pulmonologyadvisor23h
Dexamethasone Reduces Mortality Among Patients Hospitalized With COVID-19
Dexamethasone reduced mortality among patients hospitalized with COVID-19, especially those who were also receiving respiratory support.
pulmonologyadvisor23h
Paxlovid Is Safe for Low- and High-Risk Children With COVID-19
Paxlovid may offer marginal benefits for low-risk children with COVID-19; however, among high-risk children with COVID-19, Paxlovid is a safe oral option.
optometryadvisor1d
Connective Tissue Disease Treatments Affect COVID-19 Hospitalization and Morality
Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.
thecardiologyadvisor.com1d
Paxlovid Reduces COVID-19-Related Hospitalization, Death Through Day 28
Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.
Medscape1d
Paxlovid: Worth a Long Look for Easing Long COVID
New research showed some long COVID patients get symptom relief by taking an extended course of Paxlovid. Data are ...
Feeling sick? Here’s what to take and what to avoid, according to a doctor
CNN wellness expert Dr. Leana Wen suggests what to do to reduce your risk of catching respiratory viruses this winter and how to treat them if you’re sick.
Nature5d
Four lessons COVID taught us about the immune system
In the midst of pandemic upheaval, researchers have gained fundamental insights about how the body fends off infections.